Alife Health, Inc.

Alife Health is an AI-powered software platform designed to modernize and optimize the in vitro fertilization (IVF) process for fertility clinics. Founded in 2020 and based in San Francisco, the company offers a configurable ecosystem of clinical decision-support tools integrated with EMR systems. Key products include Embryo Assist™ for standardized embryo cataloging and grading (reducing nurse cryo calls by ~90%), Schedule Predict for ovarian retrieval capacity optimization (reducing overcapacity days by ~65%), Success Predictor for patient engagement and outcome monitoring, and Stim Assist for personalized gonadotropin dosing. The platform leverages interpretable machine learning models trained on fertility clinic data to provide actionable insights for embryologists, lab managers, and reproductive endocrinologists. Alife's solutions are trusted by major fertility networks including US Fertility, Ovation Fertility, Shady Grove Fertility, and others. The company is HIPAA-compliant and SOC 2 Type II certified, with peer-reviewed publications in Fertility and Sterility and RBMO validating clinical efficacy.